[1] LINN Y C,LAU S K,LIU B H,et al.Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell[J].Immunology,2009,126(3):423-435.
[2] HONTSCHA C,BORCK Y,ZHOU H,et al.Clinical trials on CIK cells:first report of the international registry on CIK cells (IRCC)[J].J Cancer Res Clin Oncol,2010,137(2):305-310.
[3] BOERMAN G H,Van OSTAIJEN-TEN DAM M M,KRAAL KC,et al.Role of NKG2D,DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells[J].Cancer Immunol Immunother,2015,64(5):573-583.
[4] 何金媛,贾祝霞,蔡晓辉,等.NKG2D在细胞因子诱导的杀伤性细胞(CIK)抗血液肿瘤细胞的作用[J].中国实验血液学杂志,2013,21(6):1380-1384
[5] 马玲娣,朱志超,卢绪章,等.苦参碱对K562细胞NKG2D配体表达的影响及机制研究[J].中华血液学杂志,2014,35(5):438-442.
[6] POGGI A,CATELLANI S,GARUTI A,et al.Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate[J].Leukemia,2009,23(4):641-648.
[7] 卢绪章,蔡晓辉,马玲娣,等.NKG2D介导正常人NK细胞对白血病细胞的杀伤作用[J].中华血液学杂志,2012,33(6):444-447
[8] CHOLUJOVA D,JAKUBIKOVA J,KUBES M,et al.Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays[J].Immunobiology,2008,213(8):629-640.
[9] FERNÁNDEZ-MESSINA L,REYBURN HT,VALÉS-GóMEZ M.Human NKG2D-ligands:cell biology strategies to ensure immune recognition[J].Front Immunol,2012,3:299.
[10] 韩文敏,贾祝霞,姜玉,等.可溶性NKG2D配体降低NK细胞对骨髓瘤细胞杀伤功能的研究[J].实用临床医药杂志,2015,19(24):134-135.
[11] JINUSHI M, VANNEMAN M,MUNSHI N C,et al.MHC class Ⅰ chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma[J].Proc Natl Acad Sci USA,2008,105(4):1285-1290.
[12] OBEIDY P,SHARLAND A F.NKG2D and its ligands[J].Int J Biochem Cell Biol,2009,41(12):2364-2367. |